Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2025-12-24 @ 5:41 PM
NCT ID:
NCT04894968
Eligibility Criteria:
Inclusion Criteria:
* At timepoint of inclusion in the LIFE-Heart study normal left ventricular ejection fraction (≥ 50%)
* At timepoint of inclusion in the LIFE-Heart study normal NT-proBNP (\< 125 ng/l)
Exclusion Criteria:
* At timepoint of inclusion in the LIFE-Heart study acute coronary syndrom
1. Troponine elevation above 14 pg/ml as well as coronary intervention, or isolated troponine elevation above 50 pg/ml in the absence of a coronary intervention
2. No troponine elevation but coronary intervention
3. Creatine kinase \> 0.41 µmol/l\*s and Creatine kinase to Creatine kinase-MB ration \>6% or Creatine kinase-MB \> 0.82 µmol/l\*s
* At timepoint of inclusion in the LIFE-Heart study missing data on left ventricular ejection fraction
* At timepoint of inclusion in the LIFE-Heart study missing NT-proBNP measurement
* At timepoint of inclusion in the LIFE-Heart study missing data on echocardiographic diastolic function and structural alterations of the left ventricle
* At timepoint of inclusion in the LIFE-Heart study relevant valvular heart disease (including relevant aortic stenosis, mitral- and/or tricuspid regurgitation, congenital heart disease, mitral stenosis)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04894968
Study Brief:
Protocol Section:
NCT04894968